TrialLancet (London, England)2002
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Björn Dahlöf et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1,177 papers cite itlatest 60 shown
this paperpooled ittrialcites it